A. A. Ciociola

437 total citations
12 papers, 349 citations indexed

About

A. A. Ciociola is a scholar working on Surgery, Gastroenterology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, A. A. Ciociola has authored 12 papers receiving a total of 349 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Surgery, 10 papers in Gastroenterology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in A. A. Ciociola's work include Gastroesophageal reflux and treatments (8 papers), Helicobacter pylori-related gastroenterology studies (7 papers) and Nausea and vomiting management (3 papers). A. A. Ciociola is often cited by papers focused on Gastroesophageal reflux and treatments (8 papers), Helicobacter pylori-related gastroenterology studies (7 papers) and Nausea and vomiting management (3 papers). A. A. Ciociola collaborates with scholars based in United States and United Kingdom. A. A. Ciociola's co-authors include Alan R. Zinsmeister, Andrea Paula Kafejian Haddad, N. J. Talley, Colleen Twomey, Robert L. MacCarty, S.F. Phillips, Philip B. Miner, Malcolm Robinson, Howard M. Proskin and D. C. Templeton and has published in prestigious journals such as Journal of Clinical Oncology, The American Journal of Gastroenterology and Alimentary Pharmacology & Therapeutics.

In The Last Decade

A. A. Ciociola

12 papers receiving 322 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. A. Ciociola United States 10 227 220 98 47 21 12 349
J. Schaffstein Germany 10 240 1.1× 193 0.9× 135 1.4× 20 0.4× 10 0.5× 18 449
J. D. George Ireland 6 212 0.9× 215 1.0× 111 1.1× 53 1.1× 5 0.2× 7 418
Tomotaka Shindo Japan 14 371 1.6× 359 1.6× 57 0.6× 78 1.7× 8 0.4× 28 573
P.A. Bianchi Italy 12 308 1.4× 221 1.0× 97 1.0× 44 0.9× 5 0.2× 23 434
Daphne Ang Singapore 16 656 2.9× 646 2.9× 104 1.1× 85 1.8× 20 1.0× 48 853
Justin CY Wu Hong Kong 4 166 0.7× 207 0.9× 25 0.3× 66 1.4× 59 2.8× 5 339
W. R. Spurrell United States 3 134 0.6× 112 0.5× 100 1.0× 22 0.5× 6 0.3× 5 338
G Beyens Belgium 5 390 1.7× 320 1.5× 56 0.6× 29 0.6× 15 0.7× 6 444
E. Lagier France 6 133 0.6× 74 0.3× 85 0.9× 10 0.2× 24 1.1× 11 254
Yasuhiro Kodaka Japan 13 276 1.2× 235 1.1× 40 0.4× 29 0.6× 19 0.9× 37 438

Countries citing papers authored by A. A. Ciociola

Since Specialization
Citations

This map shows the geographic impact of A. A. Ciociola's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. A. Ciociola with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. A. Ciociola more than expected).

Fields of papers citing papers by A. A. Ciociola

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. A. Ciociola. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. A. Ciociola. The network helps show where A. A. Ciociola may publish in the future.

Co-authorship network of co-authors of A. A. Ciociola

This figure shows the co-authorship network connecting the top 25 collaborators of A. A. Ciociola. A scholar is included among the top collaborators of A. A. Ciociola based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. A. Ciociola. A. A. Ciociola is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Ciociola, A. A., et al.. (2004). A single dose of ranitidine 150 mg modulates oesophageal acid sensitivity in patients with functional heartburn. Alimentary Pharmacology & Therapeutics. 20(9). 975–982. 28 indexed citations
2.
Orenstein, Susan R., Jeffrey L. Blumer, James A. McGuire, et al.. (2002). Ranitidine, 75 mg, over‐the‐counter dose: pharmacokinetic and pharmacodynamic effects in children with symptoms of gastro‐oesophageal reflux. Alimentary Pharmacology & Therapeutics. 16(5). 899–907. 21 indexed citations
3.
Robinson, Malcolm, et al.. (2002). Effects of antacid formulation on postprandial oesophageal acidity in patients with a history of episodic heartburn. Alimentary Pharmacology & Therapeutics. 16(3). 435–443. 16 indexed citations
4.
Gardner, Jerry D., et al.. (2002). Determination of the time of onset of action of ranitidine and famotidine on intra‐gastric acidity. Alimentary Pharmacology & Therapeutics. 16(7). 1317–1326. 8 indexed citations
5.
Robinson, Malcolm, et al.. (2001). Synergy between low‐dose ranitidine and antacid in decreasing gastric and oesophageal acidity and relieving meal‐induced heartburn. Alimentary Pharmacology & Therapeutics. 15(9). 1365–1374. 16 indexed citations
6.
Ciociola, A. A.. (1999). Helicobacter pylori infection rates in duodenal ulcer patients in the United States may be lower than previously estimated. The American Journal of Gastroenterology. 94(7). 1834–1840. 15 indexed citations
7.
Lanza, Frank L., et al.. (1998). Ranitidine Bismuth Citrate Plus Clarithromycin: A Dual Therapy Regimen for Patients with Duodenal Ulcer. Helicobacter. 3(3). 212–221. 10 indexed citations
8.
Ciociola, A. A., et al.. (1996). Dual and Triple Therapy Regimens of Antisecretory Agents and Antibiotics for the Eradication ofHelicobacter pylori: An Overview. Scandinavian Journal of Gastroenterology. 31(sup218). 3–9. 12 indexed citations
9.
Ciociola, A. A., et al.. (1996). Effects of ranitidine bismuth citrate on gastric acid secretion and gastrin release in subjects with and without Helicobacter pylori infection. Alimentary Pharmacology & Therapeutics. 10(6). 905–912. 6 indexed citations
10.
Fraschini, Giuseppe, A. A. Ciociola, Leticia Esparza, et al.. (1991). Evaluation of three oral dosages of ondansetron in the prevention of nausea and emesis associated with cyclophosphamide-doxorubicin chemotherapy.. Journal of Clinical Oncology. 9(7). 1268–1274. 34 indexed citations
11.
Talley, N. J., S.F. Phillips, Andrea Paula Kafejian Haddad, et al.. (1990). GR 38032F (Ondansetron), a selective 5HT3 receptor antagonist, slows colonic transit in healthy man. Digestive Diseases and Sciences. 35(4). 477–480. 145 indexed citations
12.
Talley, N. J., S. F. Phillips, Andrea Paula Kafejian Haddad, et al.. (1989). Effect of selective 5HT3 antagonist (GR 38032F) on small intestinal transit and release of gastrointestinal peptides. Digestive Diseases and Sciences. 34(10). 1511–1515. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026